{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:19:50Z","timestamp":1769278790424,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["20154Y0183"],"award-info":[{"award-number":["20154Y0183"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502232"],"award-info":[{"award-number":["81502232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503603"],"award-info":[{"award-number":["81503603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["JYLJ2019015"],"award-info":[{"award-number":["JYLJ2019015"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009564","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["2014LP010A"],"award-info":[{"award-number":["2014LP010A"]}],"id":[{"id":"10.13039\/501100009564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.repbio.2021.100540","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:08:03Z","timestamp":1629209283000},"page":"100540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization"],"prefix":"10.1016","volume":"21","author":[{"given":"Jing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chichiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shai E","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"7","key":"10.1016\/j.repbio.2021.100540_bib0010","article-title":"A review of second- and third-line infertility treatments and supporting evidence in women with polycystic ovary syndrome","volume":"7","author":"Costello","year":"2019","journal-title":"Med Sci (Basel)"},{"issue":"5","key":"10.1016\/j.repbio.2021.100540_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humupd\/dml020","article-title":"Ovarian feedback, mechanism of action and possible clinical implications","volume":"12","author":"Messinis","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0025","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.repbio.2021.100540_bib0035","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"21","key":"10.1016\/j.repbio.2021.100540_bib0040","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1097\/MD.0000000000000909","article-title":"Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders","volume":"15","author":"Chen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.repbio.2021.100540_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.repbio.2021.100540_bib0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fendo.2019.00325","article-title":"Anti-mullerian hormone for the prediction of ovarian response in progestin-primed ovarian stimulation protocol for IVF","volume":"10","author":"Huang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.repbio.2021.100540_bib0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2016.04.006","article-title":"Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection","volume":"106","author":"Qin","year":"2016","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.repbio.2021.100540_bib0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"Bjog"},{"key":"10.1016\/j.repbio.2021.100540_bib0080","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0085","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41598-020-57730-3","article-title":"Endometrial preparation for frozen-thawed embryo transfer in an artificial cycle: transdermal versus vaginal estrogen","volume":"10","author":"Corroenne","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.repbio.2021.100540_bib0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fendo.2019.00834","article-title":"A slower age-related decline in treatment outcomes after the first ovarian stimulation for in vitro fertilization in women with polycystic ovary syndrome","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0095","first-page":"16","article-title":"Empty follicle syndrome following GnRHa trigger in PCOS patients undergoing IVF cycles","volume":"19","author":"Deepika","year":"2018","journal-title":"J Reprod Infertil"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12958-018-0352-z","article-title":"Pregnancy outcomes of PCOS overweight\/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer","volume":"16","author":"Chen","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"10.1016\/j.repbio.2021.100540_bib0105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.repbio.2021.100540_bib0110","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/CM9.0000000000000246","article-title":"Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer","volume":"132","author":"Lin","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.repbio.2021.100540_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/492803","article-title":"Comparison of endocrine profile and in vitro fertilization outcome in patients with PCOS, ovulatory PCO, or normal ovaries","volume":"2012","author":"Zhong","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.repbio.2021.100540_bib0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10815-013-0151-6","article-title":"Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment","volume":"31","author":"Li","year":"2014","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"10.1016\/j.repbio.2021.100540_bib0125","doi-asserted-by":"crossref","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1028-4559(09)60196-0","article-title":"Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome","volume":"45","author":"Ling","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.repbio.2021.100540_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1472-6483(10)60339-2","article-title":"A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS","volume":"15","author":"Aboulghar","year":"2007","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.fertnstert.2014.09.042","article-title":"Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome","volume":"103","author":"O\u2019Neill","year":"2015","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0145","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0150","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2016.07.1068","article-title":"Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist","volume":"106","author":"Lu","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.repbio.2021.100540_bib0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.fertnstert.2014.03.047","article-title":"Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper","volume":"101","author":"Braakhekke","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jfma.2017.05.009","article-title":"Feasibility of corifollitropin alfa\/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients","volume":"117","author":"Hwang","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.repbio.2021.100540_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","article-title":"A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF","volume":"39","author":"Sha","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.repbio.2021.100540_bib0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.eprac.2020.10.020","article-title":"Early predictors of gestational diabetes mellitus in IVF-conceived pregnancies","volume":"27","author":"Coussa","year":"2021","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.repbio.2021.100540_bib0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dms018","article-title":"Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF\/ICSI: a systematic review and meta-analysis","volume":"18","author":"Pandey","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.repbio.2021.100540_bib0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2014.02.009","article-title":"Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques","volume":"176","author":"Ashrafi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"51","key":"10.1016\/j.repbio.2021.100540_bib0185","doi-asserted-by":"crossref","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.repbio.2021.100540_bib0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12884-019-2611-1","article-title":"Effects of pre-pregnancy body mass index on pregnancy and perinatal outcomes in women with PCOS undergoing frozen embryo transfer","volume":"19","author":"Lin","year":"2019","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X21000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X21000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:22:53Z","timestamp":1761646973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X21000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1642431X21000619"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2021.100540","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2021.100540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100540"}}